Digestive Disease & Surgery Institute Outcomes
Gallbladder and Abdominal Surgery
Cholecystectomy
Cholecystectomy 30-Day Outcomes (Elective and Non-Elective Cases)
2022 - 2023
| 30 Day Outcomes | 2022 % (N=493) | 2023 % (N=463) |
|---|---|---|
| Readmission | 2 | 3 |
| Procedural Re-Intervention (CD III)* | 1 | 2 |
| Bile Leak | 0 | 0 |
Data Source: Cleveland Clinic, Digestive Disease and Surgery Institute Quality Collaborative
*Any procedural intervention as defined by Clavien Dindo III – “Requiring surgical, endoscopic or radiological intervention"
Data include Main Campus, Fairview, and Hillcrest
Cholecystectomy Intraoperative Outcomes
2022 - 2023
2022 % (N) | 2023 % (N) | |
|---|---|---|
| MIS Conversion, Non-elective | 3 (25) | 2 (248) |
| MIS Conversion, Elective | 1 (776) | 1 (779) |
| Bile Duct Injury, Non-Elective | 0 (258) | 0 (255) |
| Bile Duct Injury, Elective | 0 (788) | 0 (794) |
Data Source: Cleveland Clinic, Digestive Disease and Surgery Institute Quality Collaborative
MIS = minimally invasive surgery
Data include Main Campus, Fairview, and Hillcrest
